Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for T+ B+ severe combined immunodeficiency has been reported in the published literature.
No clinical trials have been registered for T+ B+ severe combined immunodeficiency.
29 publications have been identified in PubMed for T+ B+ severe combined immunodeficiency. Research spans Basic Science / Preclinical (28%), Case Report / Case Series (24%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 8 | 28% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:01 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about T+ B+ severe combined immunodeficiency
Patient case studies
7 |
24% |
Testing and diagnosis research | 4 | 14% |
Research summaries | 4 | 14% |
New treatment approaches | 4 | 14% |
Clinical study results | 2 | 7% |
Fung ICN (2026). [PMID: 41267169](https://pubmed.ncbi.nlm.nih.gov/41267169/). *Inflamm Bowel Dis*. [Basic Science / Preclinical]
Consonni F (2026). [PMID: 41341763](https://pubmed.ncbi.nlm.nih.gov/41341763/). *J Allergy Clin Immunol Glob*. [Gene Therapy / Novel Therapeutics]
Kaczmarek S (2026). [PMID: 41453427](https://pubmed.ncbi.nlm.nih.gov/41453427/). *Cancer Lett*. [Basic Science / Preclinical]
Gunderman LM (2026). [PMID: 42088107](https://pubmed.ncbi.nlm.nih.gov/42088107/). *J Hum Immun*. [Case Report / Case Series]
Chan JY (2026). [PMID: 41652589](https://pubmed.ncbi.nlm.nih.gov/41652589/). *BMC Med*. [Gene Therapy / Novel Therapeutics]
Roy S (2026). [PMID: 41726869](https://pubmed.ncbi.nlm.nih.gov/41726869/). *bioRxiv*. [Basic Science / Preclinical]
Jacobsen EM (2026). [PMID: 41863562](https://pubmed.ncbi.nlm.nih.gov/41863562/). *J Clin Immunol*. [Clinical Trial Publication]
Marakhonov A (2026). [PMID: 41727503](https://pubmed.ncbi.nlm.nih.gov/41727503/). *Front Immunol*. [Diagnostic / Biomarker]
Anderson H (2026). [PMID: 42110384](https://pubmed.ncbi.nlm.nih.gov/42110384/). *Clin Transl Immunology*. [Review / Meta-Analysis]
Onda M (2026). [PMID: 41550974](https://pubmed.ncbi.nlm.nih.gov/41550974/). *Antib Ther*. [Gene Therapy / Novel Therapeutics]